{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:12:42Z","timestamp":1761491562115,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011937","name":"Nieders\u00e4chsische Ministerium f\u00fcr Wissenschaft und Kultur","doi-asserted-by":"publisher","award":["14-76103-184"],"award-info":[{"award-number":["14-76103-184"]}],"id":[{"id":"10.13039\/100011937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["80018019238"],"award-info":[{"award-number":["80018019238"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["39087428, 158989968"],"award-info":[{"award-number":["39087428, 158989968"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ZW7-8515131, ZW7-85151373"],"award-info":[{"award-number":["ZW7-8515131, ZW7-85151373"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Since early 2022, various Omicron variants have dominated the SARS-CoV-2 pandemic in most countries. All Omicron variants are B-cell immune escape variants, and antibodies induced by first-generation COVID-19 vaccines or by infection with earlier SARS-CoV-2 variants largely fail to protect individuals from Omicron infection. In the present study, we investigated the effect of Omicron infections in triple-vaccinated and in antigen-naive individuals. We show that Omicron breakthrough infections occurring 2\u20133.5 months after the third vaccination restore B-cell and T-cell immune responses to levels similar to or higher than those measured 14 days after the third vaccination, including the induction of Omicron-neutralizing antibodies. Antibody responses in breakthrough infection derived mostly from cross-reacting B cells, initially induced by vaccination, whereas Omicron infections in antigen-naive individuals primarily generated B cells binding to the Omicron but not the Wuhan spike protein. Although antigen-naive individuals mounted considerable T-cell responses after infection, B-cell responses were low, and neutralizing antibodies were frequently below the limit of detection. In summary, the detection of Omicron-associated B-cell responses in primed and in antigen-naive individuals supports the application of Omicron-adapted COVID-19 vaccines, but calls into question their suitability if they also contain\/encode antigens of the original Wuhan virus.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1166589","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:33:26Z","timestamp":1683264806000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals"],"prefix":"10.3389","volume":"14","author":[{"given":"Joana","family":"Barros-Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swantje I.","family":"Hammerschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Morillas Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Cossmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hetzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Odak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metodi V.","family":"Stankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Friedrichsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Ravens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Schimrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmin","family":"Ristenpart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anika","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Willenzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Lichtinghagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berislav","family":"Bo\u0161njak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg M. N.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhold","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","article-title":"The omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the covid-19 pandemic","volume":"185","author":"Hoffmann","year":"2022","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2111026","article-title":"Vitt after Chadox1 ncov-19 vaccination","volume":"385","author":"Greinacher","year":"2021","journal-title":"Reply. N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune responses against sars-Cov-2 variants after heterologous and homologous Chadox1 ncov-19\/Bnt162b2 vaccination","volume":"27","author":"Barros-Martins","year":"2021","journal-title":"Nat Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1038\/s41467-022-32321-0","article-title":"Comparative immunogenicity and reactogenicity of heterologous Chadox1-Ncov-19-Priming and Bnt162b2 or mrna-1273-Boosting with homologous covid-19 vaccine regimens","volume":"13","author":"Klemis","year":"2022","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01464-w","article-title":"Immunogenicity and reactogenicity of heterologous Chadox1 ncov-19\/Mrna vaccination","volume":"27","author":"Schmidt","year":"2021","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00357-X","article-title":"Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with Chadox1 ncov-19 and Bnt162b2: a prospective cohort study","volume":"9","author":"Hillus","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1038\/s41467-022-32527-2","article-title":"Bnt162b2-boosted immune responses six months after heterologous or homologous Chadox1ncov-19\/Bnt162b2 vaccination against covid-19","volume":"13","author":"Behrens","year":"2022","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01461-0","article-title":"Perceived versus proven sars-Cov-2-Specific immune responses in health-care professionals","volume":"48","author":"Behrens","year":"2020","journal-title":"Infection"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.02.20242479","article-title":"Protocol for longitudinal assessment of sars-Cov-2-Specific immune responses in healthcare professionals in hannover, Germany: the prospective, longitudinal, observational covid-19 contact (Coco) study","author":"Jablonka","year":"2020","journal-title":"medRxiv"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1038\/s41467-022-32254-8","article-title":"Levels of sars-Cov-2 antibodies among fully vaccinated individuals with delta or omicron variant breakthrough infections","volume":"13","author":"Staerke","year":"2022","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent sars-Cov-2 omicron-reactive T and b cell responses in covid-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Sci Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.cell.2022.03.019","article-title":"Neutralizing immunity in vaccine breakthrough infections from the sars-Cov-2 omicron and delta variants","volume":"185","author":"Servellita","year":"2022","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04865-0","article-title":"Limited cross-variant immunity from sars-Cov-2 omicron without vaccination","volume":"607","author":"Suryawanshi","year":"2022","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28419","article-title":"Omicron infection increases igg binding to spike protein of predecessor variants","volume":"95","author":"Mahalingam","year":"2022","journal-title":"J Med Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04830-x","article-title":"Omicron infection enhances delta antibody immunity in vaccinated persons","volume":"607","author":"Khan","year":"2022","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.08.491108","article-title":"Imprinted antibody responses against sars-Cov-2 omicron sublineages","author":"Park","year":"2022","journal-title":"bioRxiv"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq2427","article-title":"Omicron Ba.1 breakthrough infection drives cross-variant neutralization and memory b cell formation against conserved epitopes","volume":"7","author":"Quandt","year":"2022","journal-title":"Sci Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41421-022-00472-5","article-title":"Neutralization of omicron Ba.4\/Ba.5 and Ba.2.75 by booster vaccination or Ba.2 breakthrough infection sera","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Discov"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade2283","article-title":"Omicron Ba.2 breakthrough infection enhances cross-neutralization of Ba.2.12.1 and Ba.4\/Ba.5","volume":"7","author":"Muik","year":"2022","journal-title":"Sci Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1166589\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:33:30Z","timestamp":1683264810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1166589\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2023.1166589"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1166589","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"article-number":"1166589"}}